Report No. 25/2026 Submission of Draft Resolutions for the Ordinary General Meeting of Shareholders Przekaż swoją opinię na temat programu BizChat

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”) hereby announces that it has received from a shareholder representing at least one-twentieth of the Company’s share capital, namely TOTAL Closed-End Investment Fund (TOTAL Fundusz Inwestycyjny Zamknięty), a submission of draft resolutions pursuant to Article 401 […]

Report No. 24/2026 Update on the timeline for receiving the final list of questions from the EMA in the process of obtaining a positive recommendation for the marketing authorisation of the veterinary medicinal product BCX-CM-J.

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”), with reference to ESPI Current Report No. 11/2026 dated 14 May 2026, in which the Issuer informed about receiving confirmation of the submission to the European Medicines Agency (the “EMA”) of documentation containing explanations and responses […]